Reduction in the Frequency of Sickle Cell Crisis, Frequency in Hospitalizations, Hospital Days and Fewer Cases of Acute Chest Syndrome Highlighted in Abstract
Investigator(s): The Lundquist Institute
LA BioMed Researchers Find Novel NDV-3 Vaccine Protects Against MRSA
LOS ANGELES – (Dec. 8, 2014) – In the U.S. and around the globe, skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) continue to endanger the health and lives of patients and otherwise healthy individuals. Treatment is difficult because MRSA is resistant to many antibiotics, and the infections can recur, placing family members and other close contacts at risk of infection.